INARI MEDICAL, INC.

(NARI)
  Report
Real-time Estimate Cboe BZX  -  09:39 2022-06-30 am EDT
67.88 USD   -2.02%
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell Small Cap Comp Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000E Value Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inari Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

05/04/2022 | 04:01pm EDT

Inari Medical, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 86.75 million compared to USD 57.4 million a year ago. Net loss was USD 3.13 million compared to net income of USD 7.47 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to basic earnings per share from continuing operations of USD 0.15 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to diluted earnings per share from continuing operations of USD 0.13 a year ago.


© S&P Capital IQ 2022
All news about INARI MEDICAL, INC.
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell Small Cap Comp Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000E Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 2500 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 2000 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) dropped from Russell 2000 Growth-Defensive Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) dropped from Russell 2000 Defensive Index
CI
06/21Inari Medical's Shares Rise After Piper Sandler Initiates Coverage
MT
06/21Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 365 M - -
Net income 2022 -38,5 M - -
Net cash 2022 316 M - -
P/E ratio 2022 -93,1x
Yield 2022 -
Capitalization 3 681 M 3 681 M -
EV / Sales 2022 9,22x
EV / Sales 2023 7,71x
Nbr of Employees 800
Free-Float 84,9%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 69,28 $
Average target price 105,00 $
Spread / Average Target 51,6%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-24.09%3 681
NOVOCURE LIMITED-3.57%7 572
MASIMO CORPORATION-53.18%7 555
SHOCKWAVE MEDICAL, INC.8.99%6 957
GETINGE AB-40.60%6 259
IRAY TECHNOLOGY COMPANY LIMITED-8.15%4 941